Symposium on Severe Mental Illness
On The Frontier Of Translational Neuroscience
This two-day virtual symposium will bring together scientists working on the frontiers of genetics, neurobiology, computational psychiatry, and therapeutic development for schizophrenia, bipolar disorder, autism spectrum disorder, and related neuropsychiatric disorders. The symposium is chaired by Dr. Steve Hyman, director of the Stanley Center for Psychiatric Research at Broad Institute, Dr. Guoping Feng of McGovern Institute at MIT and director of the Neurobiology and Model Systems group of the Stanley Center, and Dr. Benjamin Neale of Massachusetts General Hospital and director of Genetics at the Stanley Center. The central theme this year will address the challenges of turning biological insights from the developing brain into translational hypotheses that can help patients. Our speakers will present progress in analytic approaches, technologies, and model systems that will help translate results from large-scale genetic studies into new understandings of pathophysiology, biomarker development, and much-needed new treatments.
The illnesses highlighted in this symposium cause lifelong disability to millions of persons — combined, more than 3 percent of the global population is affected by these severe disorders. Graduate students and postdoctoral associates are especially welcomed to this symposium in order to build this interdisciplinary field and address the unmet medical needs of patients and their families at a time of great opportunity and urgency.
You will receive the webcast link by Friday, September 17.